PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 116 filers reported holding PULMONX CORP in Q2 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,844,270 | -52.8% | 448,623 | -31.0% | 0.00% | -66.7% |
| Q1 2024 | $6,027,669 | -41.2% | 650,234 | -19.1% | 0.00% | -25.0% |
| Q4 2023 | $10,251,293 | +163.5% | 804,023 | +113.5% | 0.00% | +100.0% |
| Q3 2023 | $3,890,619 | -52.8% | 376,633 | -40.1% | 0.00% | -50.0% |
| Q2 2023 | $8,247,121 | +510874.0% | 629,071 | +335.6% | 0.00% | +300.0% |
| Q1 2023 | $1,614 | +190.8% | 144,400 | +119.5% | 0.00% | – |
| Q4 2022 | $555 | -100.0% | 65,780 | -42.2% | 0.00% | -100.0% |
| Q2 2022 | $1,675,000 | -28.0% | 113,823 | +21.5% | 0.00% | -50.0% |
| Q1 2022 | $2,325,000 | +35.8% | 93,680 | +75.4% | 0.00% | – |
| Q4 2021 | $1,712,000 | +288.2% | 53,407 | +434.1% | 0.00% | – |
| Q2 2021 | $441,000 | -97.2% | 10,000 | -97.1% | 0.00% | -100.0% |
| Q1 2021 | $15,540,000 | – | 339,742 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $886,000 | 3.13% |
| PURA VIDA INVESTMENTS, LLC | 1,327,065 | $19,534,000 | 1.13% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,465,901 | $51,018,000 | 1.05% |
| NEXT CENTURY GROWTH INVESTORS LLC | 453,098 | $6,669,000 | 0.87% |
| Novo Holdings A/S | 510,555 | $7,515,000 | 0.37% |
| Rock Springs Capital Management LP | 702,400 | $10,339,000 | 0.30% |
| RTW INVESTMENTS, LP | 691,255 | $10,175,000 | 0.26% |
| TimesSquare Capital Management, LLC | 1,214,204 | $17,873,000 | 0.25% |
| FORMULA GROWTH LTD | 54,951 | $809,000 | 0.22% |
| Champlain Investment Partners, LLC | 2,129,760 | $31,350,000 | 0.20% |